Comparison of the Single-Dose Pharmacokinetics of Once-Daily Cyclobenzaprine Extended-Release 30 mg and Cyclobenzaprine Immediate-Release 10 mg Three Times Daily in the Elderly: A Randomized, Open-Label, Crossover Study

By Darwish Mona  

Drugs & Aging, Vol. 26, Iss. 2, 2009-01 ,pp. : 95-101

Adis International

Access to resources Recommend Favorite

Pharmacokinetics of a New Once-Daily Controlled-Release Formulation of Aceclofenac in Korean Healthy Subjects Compared with Immediate-Release Aceclofenac and the Effect of Food: A Randomized, Open-Label, Three-Period, Crossover, Single-Centre Study

By >  

Clinical Drug Investigation, Vol. 32, Iss. 2, 2012-02 ,pp. : 111-119

Adis International

Access to resources Recommend Favorite

Pharmacokinetic profile of once-daily cyclobenzaprine extended-release

By Darwish Mona   Hellriegel Edward T  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 11, 2010-11 ,pp. : 1425-1436

Informa Healthcare

Access to resources Recommend Favorite

Influence of Cytochrome P450 3A5 (CYP3A5) Genetic Polymorphism on the Pharmacokinetics of the Prolonged-Release, Once-Daily Formulation of Tacrolimus in Stable Renal Transplant Recipients

By Glowacki François   Lionet Arnaud  

Clinical Pharmacokinetics, Vol. 50, Iss. 7, 2011-07 ,pp. : 451-459

Adis International

Access to resources Recommend Favorite

Single‐ and Multiple‐Dose Pharmacokinetics of Once‐Daily Formulations of Raltegravir

By  

Clinical Pharmacology In Drug Development, Vol. 7, Iss. 2, 2018-02 ,pp. : 196-206

John Wiley & Sons Inc

Access to resources Recommend Favorite